Entera Bio Ltd.

ENTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.98

+$0.02 (+0.68%)

Sep 22, 2026, 2:15 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $145.9M

Enterprise Value $135.01M

Beta 1.39

Average Volume 2.55M

Shares Outstanding (Diluted) 50.45M

Shares Change YoY 7.72%

Institutional Ownership 16.48%

Exchange NASDAQ

ISIN IL0011429839

Price Performance

Price Change 1M -9.8%

Price Change 3M 91.0%

Price Change 6M 150.8%

Price Change YTD 67.2%

Price Change 1Y 63.5%

Price Change 3Y 316.9%

Price Change 5Y -38.5%

1M CAGR (ann.) 3.1%

1Y CAGR (ann.) 64.4%

5Y CAGR (ann.) -8.2%

All-Time CAGR -8.7%

Valuation

PE Ratio -44.38

Forward PE N/A

PEG Ratio 0.06

Forward PEG -0.15

PS Ratio N/A

Forward PS 25,836.50

PB Ratio 20.08

P/FCF Ratio -12.80

P/Adj. FCF Ratio -11.49

P/OCF Ratio -13.45

EV/Sales N/A

EV/EBIT -9.45

EV/EBITDA -9.47

EV/FCF -11.84

Earnings Yield -2.3%

FCF Yield -7.8%

Adj. FCF Yield -8.7%

Financial Health

Net Cash $10.88M

Total Debt $425K

Cash & Short-Term Investments $11.31M

Total Assets $19.48M

Current Ratio 8.98

Quick Ratio 8.98

Debt / Equity Ratio 0.06

Debt / EBITDA -0.03

Debt / FCF -0.04

OCF / Debt -26.64

Interest Coverage -5.24

Altman Z-Score -4.01

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -11.4%

Returns

Return on Assets -87.4%

Return on Equity -147.2%

Return on Invested Capital -81.9%

Return on Capital Employed -82.9%

Return on Tangible Assets -87.4%

Historical Growth (CAGR)

Revenue CAGR 3Y -38.3%

Revenue CAGR 5Y -52.1%

Revenue CAGR 10Y -6.7%

EPS CAGR 3Y 68.2%

EPS CAGR 5Y -1281.5%

EPS CAGR 10Y 28.1%

FCF CAGR 3Y -24.7%

FCF CAGR 5Y 3.6%

FCF CAGR 10Y -3.2%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y -142.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 12, 2026

EPS Estimate (next Q) -$0.07

EPS Growth Est (next Q) -7.1%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $9

Price Target Upside 204.1%

Cash Flow

Operating Cash Flow $-11.32M

Free Cash Flow $-11.4M

Adj. Free Cash Flow $-12.7M

FCF Per Share -$0.23

OCF Per Share -$0.22

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-15K

Operating Income $-14.4M

EBITDA $-14.25M

Net Income $-2.41M

EPS (Diluted) -$0.07

Revenue / Employee N/A

Profit / Employee $-114.71K

Employees 21